Compare Stocks: PLRZ vs. CLRB vs. CYCN vs. LPCN
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
PLRZCLRBCYCNLPCN
Market Snapshot
Current market context for the selected companies.
PLRZ
$10.30
Market Cap
$21.46M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
CLRB
$2.59
Market Cap
$24.48M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
CYCN
$3.89
Market Cap
$18.21M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
LPCN
$2.09
Market Cap
$17.23M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
Performance
Absolute returns and relative performance versus SPY.
| Metric | PLRZ | CLRB | CYCN | LPCN |
|---|---|---|---|---|
| 1 Month | -32.7% | +4.9% | +7.5% | -4.6% |
| 1 Month vs SPY | -36.5% | +1.1% | +3.7% | -8.3% |
| 3 Months | -18.6% | -18.3% | +23.1% | -5.9% |
| 3 Months vs SPY | -21.7% | -21.4% | +20.0% | -9.0% |
| 6 Months | -20.9% | -23.4% | +190.3% | -78.7% |
| 6 Months vs SPY | -32.0% | -34.4% | +179.2% | -89.7% |
| 1 Year | +57.5% | -41.3% | +63.4% | -31.2% |
| 1 Year vs SPY | +37.5% | -61.3% | +43.4% | -51.2% |
| 2 Years | — | -95.7% | +55.0% | -43.5% |
| 2 Years vs SPY | — | -133.9% | +16.8% | -81.7% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.